| Dr Clifford C Cloonan, MD | |
|
6481 Carlisle Pike, Mechanicsburg, PA 17050-2377 | |
| (717) 516-6396 | |
| (717) 620-8093 |
| Full Name | Dr Clifford C Cloonan |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 6481 Carlisle Pike, Mechanicsburg, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003854753 | NPI | - | NPPES |
| 100920847 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD423158 (Pennsylvania) | Secondary |
| 207P00000X | Emergency Medicine | MD423158 (Pennsylvania) | Primary |
| Entity Name | Upmc Altoona |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497831655 PECOS PAC ID: 8426962465 Enrollment ID: O20040406001094 |
News Archive
Atrial fibrillation patients with a history of cancer are less likely to see a cardiologist or fill anticoagulant prescriptions compared with AFib patients who never had cancer, according to a study in the Journal of the American College of Cardiology.
Otsuka Pharmaceutical Co., Ltd. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Deltyba (delamanid) in combination with a WHO recommended optimized background regimen for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB). The CHMP opinion will help form the basis for a European Commission decision expected early next year.
Merge Healthcare, a health IT solutions leader, today announced it will be showcasing it's expanded suite of innovative solutions and support of comprehensive continuing education programs for the advancement of women's imaging at the National Conference on Breast Cancer (NCBC) 2010. Additionally, Merge plans to introduce and collaborate with attendees on its Women's Healthcare Initiative, which builds partnerships with clinicians to provide broader access to training in the analysis and interpretation of these important studies.
In an article published today by SAGE Publishing, investigators from The Nagourney Cancer Institute and The Albert Einstein Israelite Hospital in São Paulo, Brazil, announced a new approach to identifying effective treatments for patients with advanced metastatic cancers. A drug commonly used to treat kidney and liver cancer was discovered effective for breast cancer, which may open new drug therapies to patients regardless of tumor type.
› Verified 9 days ago
| Entity Name | Emergency Care Services Of Pennsylvania Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114955010 PECOS PAC ID: 1759301799 Enrollment ID: O20051206000046 |
News Archive
Atrial fibrillation patients with a history of cancer are less likely to see a cardiologist or fill anticoagulant prescriptions compared with AFib patients who never had cancer, according to a study in the Journal of the American College of Cardiology.
Otsuka Pharmaceutical Co., Ltd. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Deltyba (delamanid) in combination with a WHO recommended optimized background regimen for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB). The CHMP opinion will help form the basis for a European Commission decision expected early next year.
Merge Healthcare, a health IT solutions leader, today announced it will be showcasing it's expanded suite of innovative solutions and support of comprehensive continuing education programs for the advancement of women's imaging at the National Conference on Breast Cancer (NCBC) 2010. Additionally, Merge plans to introduce and collaborate with attendees on its Women's Healthcare Initiative, which builds partnerships with clinicians to provide broader access to training in the analysis and interpretation of these important studies.
In an article published today by SAGE Publishing, investigators from The Nagourney Cancer Institute and The Albert Einstein Israelite Hospital in São Paulo, Brazil, announced a new approach to identifying effective treatments for patients with advanced metastatic cancers. A drug commonly used to treat kidney and liver cancer was discovered effective for breast cancer, which may open new drug therapies to patients regardless of tumor type.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Clifford C Cloonan, MD 409 S 2nd St, Suite 2f, Harrisburg, PA 17104-1612 Ph: () - | Dr Clifford C Cloonan, MD 6481 Carlisle Pike, Mechanicsburg, PA 17050-2377 Ph: (717) 516-6396 |
News Archive
Atrial fibrillation patients with a history of cancer are less likely to see a cardiologist or fill anticoagulant prescriptions compared with AFib patients who never had cancer, according to a study in the Journal of the American College of Cardiology.
Otsuka Pharmaceutical Co., Ltd. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Deltyba (delamanid) in combination with a WHO recommended optimized background regimen for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB). The CHMP opinion will help form the basis for a European Commission decision expected early next year.
Merge Healthcare, a health IT solutions leader, today announced it will be showcasing it's expanded suite of innovative solutions and support of comprehensive continuing education programs for the advancement of women's imaging at the National Conference on Breast Cancer (NCBC) 2010. Additionally, Merge plans to introduce and collaborate with attendees on its Women's Healthcare Initiative, which builds partnerships with clinicians to provide broader access to training in the analysis and interpretation of these important studies.
In an article published today by SAGE Publishing, investigators from The Nagourney Cancer Institute and The Albert Einstein Israelite Hospital in São Paulo, Brazil, announced a new approach to identifying effective treatments for patients with advanced metastatic cancers. A drug commonly used to treat kidney and liver cancer was discovered effective for breast cancer, which may open new drug therapies to patients regardless of tumor type.
› Verified 9 days ago
Manuela Maria Orzea Modelewski, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1995 Technology Pkwy, Mechanicsburg, PA 17050 Phone: 717-231-8772 | |
Paul Modelewski, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1995 Technology Pkwy, Mechanicsburg, PA 17050 Phone: 717-231-8772 | |
Dr. Marlys J Pike, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6481 Carlisle Pike, Mechanicsburg, PA 17050 Phone: 717-796-9355 Fax: 717-620-8093 | |
Dr. Gregory J Smolin, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 6481 Carlisle Pike, Mechanicsburg, PA 17050 Phone: 717-516-6396 Fax: 717-620-8093 | |
Richard D Stagg, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 120 S Filbert St, Mechanicsburg, PA 17055 Phone: 717-795-6656 Fax: 717-795-6658 | |
Yolanda Marion Michetti, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2025 Technology Pkwy Ste G07, Mechanicsburg, PA 17050 Phone: 717-791-2440 Fax: 717-791-2441 | |
Roy E Monsour, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2025 Technology Pkwy Ste 301, Mechanicsburg, PA 17050 Phone: 717-642-5666 Fax: 717-642-4292 |